glp-1 and gastroparesis Implications of the era on health TrimRX | GLP-1 vs GIP:

These tend to be individuals with pre-existing gastroparesis, irritable bowel syndrome, or other digestive conditions that amplify the gastric emptying delay

it is not a direct substitute for a balanced diet, clinical dermatological treatments, or a healthy lifestyle, nor is it intended to diagnose, treat, cure, or prevent any chronic health issue or medical condition

WIRES Nanomed Nanobi 9 (2), e1410

Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells

This growth has largely been driven by the commercial successes of GLP-1R agonists, such as Novo Nordisk's semaglutide (Wegovy) and Eli Lilly's tirzepatide (Zepbound)

If side effects become bothersome or unmanageable, he may recommend interventions such as dose reduction or changes in lifestyle factors